SHEENA BLAKE: Open Payments
NPI 1083218820 · ELKTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 47 payments from 16 companies in 2025. Trend: 2023 $722 · 2024 $478 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $271 |
| Supernus Pharmaceuticals, Inc. | 1 | $117 |
| ABBVIE INC. | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| Corium, LLC | 4 | $76 |
| Novo Nordisk Inc | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| PFIZER INC. | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Biogen, Inc. | 1 | $23 |
Products named: CAPLYTA, Qelbree, VRAYLAR, Azstarys, REXULTI, Ozempic, HETLIOZ, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
